Schmidt M, Nitz U, Reimer T, Schmatloch S, et al. Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial. Eur J Cancer 2023;194:113324.
PMID: 37797387